PT  - JOURNAL ARTICLE
AU  - Jenna M. Swarthout
AU  - Erica R. Fuhrmeister
AU  - Latifah Hamzah
AU  - Angela R. Harris
AU  - Mir A. Ahmed
AU  - Emily S. Gurley
AU  - Syed M. Satter
AU  - Alexandria B. Boehm
AU  - Amy J. Pickering
TI  - Differential overlap in human and animal fecal microbiomes and resistomes in rural versus urban Bangladesh
AID  - 10.1101/2021.05.13.21257188
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.13.21257188
4099  - http://medrxiv.org/content/early/2021/05/18/2021.05.13.21257188.short
4100  - http://medrxiv.org/content/early/2021/05/18/2021.05.13.21257188.full
AB  - Background Low- and middle-income countries (LMICs) bear the largest mortality burden due to antimicrobial-resistant infections. Small-scale animal production and free-roaming domestic animals are common in many LMICs, yet data on zoonotic exchange of gut bacteria and antimicrobial resistance genes (ARGs) in low-income communities are sparse. Differences between rural and urban communities in population density, antibiotic use, and cohabitation with animals likely influence the frequency of transmission of gut bacterial communities and ARGs between humans and animals. Here, we determined the similarity in gut microbiomes, using 16S rRNA gene amplicon sequencing, and resistomes, using long-read metagenomics, between humans, chickens, and goats in rural compared to urban Bangladesh.Results Gut microbiomes were more similar between humans and chickens in rural (where cohabitation is more common) compared to urban areas, but there was no difference for humans and goats. Urbanicity did not impact the similarity of human and animal resistomes; however, ARG abundance was higher in urban animals compared to rural animals. We identified substantial overlap of ARG alleles in humans and animals in both settings. Humans and chickens had more overlapping ARG alleles than humans and goats. All fecal hosts carried ARGs on contigs classified as potentially pathogenic bacteria – including Escherichia coli, Campylobacter jejuni, Clostridiodes difficile, and Klebsiella pneumoniae.Conclusions While the development of antimicrobial resistance in animal gut microbiomes and subsequent transmission to humans has been demonstrated in intensive farming environments and high-income countries, evidence of zoonotic exchange of antimicrobial resistance in LMIC communities is lacking. This research provides genomic evidence of overlap of antimicrobial resistance genes between humans and animals, especially in urban communities, and highlights chickens as important reservoirs of antimicrobial resistance. Chicken and human gut microbiomes were more similar in rural Bangladesh, where cohabitation is more common. Incorporation of long-read metagenomics enabled characterization of bacterial hosts of resistance genes, which has not been possible in previous culture-independent studies using only short-read sequencing. These findings highlight the importance of developing strategies for combatting antimicrobial resistance that account for chickens being reservoirs of ARGs in community environments, especially in urban areas.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis was not a clinical trial.Funding StatementThis work was supported, in part, by the Bill & Melinda Gates Foundation [OPPGD759] to the University of California Berkeley. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. Lab processing was funded by a Tufts Institute of the Environment Environmental Research Fellowship awarded to JS and AJP's start-up funds at Tufts University. This material is based upon work supported by the NSF Postdoctoral Research Fellowships in Biology Program under Grant No. 1906957. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The studies were approved by the icddr,b Ethical Review Committee (PR-11063, PR-13004), Johns Hopkins University Institutional Review Board (IRB) (00004795), University of California, Berkeley Committee for the Protection of Human Subjects (2011-09-3652), and Stanford University IRB (25863).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMetagenomic sequence reads and 16S rRNA amplicon sequences are available in the sequence read archive (SRA) under accession numbers SRR13059261- SRR13059374. Human sequences were removed from all samples. Relevant analysis scripts are available in GitHub (https://github.com/jennaswa/arg_bd).LMIClow- and middle-income countryARGantimicrobial resistance geneUSDAUnited States Department of AgriculturePCRpolymerase chain reactionONTOxford Nanopore TechnologiesASVamplicon sequence variantNCBINational Center for Biotechnology InformationCDCCenters for Disease Control and PreventionMLSmacrolide, lincosamide, and streptogramin BESBLextended-spectrum beta-lactamaseBLIbeta-lactamase inhibitor